The extended pluripotency protein interactome and its links to reprogramming

Current Opinion in Genetics and Development

Volumn 28, Issue , 2014, Pages 16-24

  Huang, Xin ^a   Wang, Jianlong ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; PROTEIN;

EMBRYONIC STEM CELL; HUMAN; MASS SPECTROMETRY; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; SOMATIC CELL; ANIMAL; CYTOLOGY; METABOLISM; PLURIPOTENT STEM CELL; PROTEIN DOMAIN; AFFINITY PURIFICATION COUPLED WITH MASS SPECTROMETRY; BINDING AFFINITY; CELL INTERACTION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; COMPLEX FORMATION; DEACETYLATION; GENE LOCUS; GENETIC REGULATION; HISTONE ACETYLATION; HISTONE DEMETHYLATION; PROTEIN EXPRESSION;

ANIMALS; CELLULAR REPROGRAMMING; HUMANS; PLURIPOTENT STEM CELLS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEINS;

EID: 84906519688     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2014.08.003     Document Type: Review

References (69)

1. Silva J., Smith A. Capturing pluripotency. Cell 2008, 132:532-536.
2. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
3. Plath K., Lowry W.E. Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet 2011, 12:253-265.
4. Cherry A.B., Daley G.Q. Reprogramming cellular identity for regenerative medicine. Cell 2012, 148:1110-1122.
5. Lee T.I., Jenner R.G., Boyer L.A., Guenther M.G., Levine S.S., Kumar R.M., Chevalier B., Johnstone S.E., Cole M.F., Isono K., Koseki H., et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006, 125:301-313.
6. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., Wong E., Orlov Y.L., Zhang W., Jiang J., Loh Y.H., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
7. Wang J., Trowbridge J.J., Rao S., Orkin S.H. Proteomic studies of stem cells 2008.
8. Wang J. Deciphering protein complexes and protein interaction networks for stem cell pluripotency. New Frontiers of Network Analysis in Systems Biology 2012, 97-118. Springer, Netherlands. A. Ma'ayan, B.D. MacArthur (Eds.).
9. Spruijt C.G., Baymaz H.I., Vermeulen M. Identifying specific protein-DNA interactions using SILAC-based quantitative proteomics. Methods Mol Biol 2013, 977:137-157.
10. Wang J., Rao S., Chu J., Shen X., Levasseur D.N., Theunissen T.W., Orkin S.H. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006, 444:364-368.
11. Festuccia N., Osorno R., Wilson V., Chambers I. The role of pluripotency gene regulatory network components in mediating transitions between pluripotent cell states. Curr Opin Genet Dev 2013, 23:504-511.
12. Lu R., Markowetz F., Unwin R.D., Leek J.T., Airoldi E.M., MacArthur B.D., Lachmann A., Rozov R., Ma'ayan A., Boyer L.A., Troyanskaya O.G., et al. Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature 2009, 462:358-362.
13. Costa Y., Ding J., Theunissen T.W., Faiola F., Hore T.A., Shliaha P.V., Fidalgo M., Saunders A., Lawrence M., Dietmann S., Das S., et al. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature 2013, 495:370-374.
14. Gagliardi A., Mullin N.P., Ying Tan Z., Colby D., Kousa A.I., Halbritter F., Weiss J.T., Felker A., Bezstarosti K., Favaro R., Demmers J., et al. A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. EMBO J 2013, 32:2231-2247.
15. Liang J., Wan M., Zhang Y., Gu P., Xin H., Jung S.Y., Qin J., Wong J., Cooney A.J., Liu D., Songyang Z. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol 2008, 10:731-739.
16. van den Berg D.L., Zhang W., Yates A., Engelen E., Takacs K., Bezstarosti K., Demmers J., Chambers I., Poot R.A. Estrogen-related receptor beta interacts with Oct4 to positively regulate Nanog gene expression. Mol Cell Biol 2008, 28:5986-5995.
17. Festuccia N., Osorno R., Halbritter F., Karwacki-Neisius V., Navarro P., Colby D., Wong F., Yates A., Tomlinson S.R., Chambers I. Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell 2012, 11:477-490.
18. van den Berg D.L., Snoek T., Mullin N.P., Yates A., Bezstarosti K., Demmers J., Chambers I., Poot R.A. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 2010, 6:369-381.
19. Pardo M., Lang B., Yu L., Prosser H., Bradley A., Babu M.M., Choudhary J. An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 2010, 6:382-395.
20. Ding J., Xu H., Faiola F., Ma'ayan A., Wang J. Oct4 links multiple epigenetic pathways to the pluripotency network. Cell Res 2012, 22:155-167.
21. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000, 24:372-376.
22. Kim J., Woo A.J., Chu J., Snow J.W., Fujiwara Y., Kim C.G., Cantor A.B., Orkin S.H. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 2010, 143:313-324.
23. Fazzio T.G., Huff J.T., Panning B. An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity. Cell 2008, 134:162-174.
24. Ho L., Ronan J.L., Wu J., Staahl B.T., Chen L., Kuo A., Lessard J., Nesvizhskii A.I., Ranish J., Crabtree G.R. An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci U S A 2009, 106:5181-5186.
25. Ho L., Jothi R., Ronan J.L., Cui K., Zhao K., Crabtree G.R. An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci U S A 2009, 106:5187-5191.
26. Fong Y.W., Inouye C., Yamaguchi T., Cattoglio C., Grubisic I., Tjian R. A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells. Cell 2011, 147:120-131.
27. Fong Y.W., Cattoglio C., Yamaguchi T., Tjian R. Transcriptional regulation by coactivators in embryonic stem cells. Trends Cell Biol 2012, 22:292-298.
28. Buganim Y., Faddah D.A., Jaenisch R. Mechanisms and models of somatic cell reprogramming. Nat Rev Genet 2013, 14:427-439.
29. Polo J.M., Anderssen E., Walsh R.M., Schwarz B.A., Nefzger C.M., Lim S.M., Borkent M., Apostolou E., Alaei S., Cloutier J., Bar-Nur O., et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012, 151:1617-1632.
30. Feng B., Jiang J., Kraus P., Ng J.H., Heng J.C., Chan Y.S., Yaw L.P., Zhang W., Loh Y.H., Han J., Vega V.B., et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol 2009, 11:197-203.
31. Singhal N., Graumann J., Wu G., Arauzo-Bravo M.J., Han D.W., Greber B., Gentile L., Mann M., Scholer H.R. Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell 2010, 141:943-955.
32. Esch D., Vahokoski J., Groves M.R., Pogenberg V., Cojocaru V., Vom Bruch H., Han D., Drexler H.C., Arauzo-Bravo M.J., Ng C.K., Jauch R., et al. A unique Oct4 interface is crucial for reprogramming to pluripotency. Nat Cell Biol 2013, 15:295-301.
33. Luo M., Ling T., Xie W., Sun H., Zhou Y., Zhu Q., Shen M., Zong L., Lyu G., Zhao Y., Ye T., et al. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells. Stem Cells 2013, 31:1278-1286.
34. Reynolds N., Latos P., Hynes-Allen A., Loos R., Leaford D., O'Shaughnessy A., Mosaku O., Signolet J., Brennecke P., Kalkan T., Costello I., et al. NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment. Cell Stem Cell 2012, 10:583-594.
35. Rais Y., Zviran A., Geula S., Gafni O., Chomsky E., Viukov S., Mansour A.A., Caspi I., Krupalnik V., Zerbib M., Maza I., et al. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 2013, 502:65-70.
36. Dos Santos R.L., Tosti L., Radzisheuskaya A., Caballero I.M., Kaji K., Hendrich B., Silva J.C. MBD3/NuRD facilitates induction of pluripotency in a context-dependent manner. Cell Stem Cell 2014, 15:102-110.
37. Wang S., Xia P., Ye B., Huang G., Liu J., Fan Z. Transient activation of autophagy via Sox2-mediated suppression of mTOR is an important early step in reprogramming to pluripotency. Cell Stem Cell 2013, 13:617-625.
38. Fidalgo M., Faiola F., Pereira C.F., Ding J., Saunders A., Gingold J., Schaniel C., Lemischka I.R., Silva J.C., Wang J. Zfp281 mediates Nanog autorepression through recruitment of the NuRD complex and inhibits somatic cell reprogramming. Proc Natl Acad Sci U S A 2012, 109:16202-16207.
39. Deplus R., Delatte B., Schwinn M.K., Defrance M., Mendez J., Murphy N., Dawson M.A., Volkmar M., Putmans P., Calonne E., Shih A.H., et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J 2013, 32:645-655.
40. Shi F.T., Kim H., Lu W., He Q., Liu D., Goodell M.A., Wan M., Songyang Z. Ten-eleven translocation 1 (Tet1) is regulated by O-linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells. J Biol Chem 2013, 288:20776-20784.
41. Chen Q., Chen Y., Bian C., Fujiki R., Yu X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 2013, 493:561-564.
42. McDonel P., Demmers J., Tan D.W., Watt F., Hendrich B.D. Sin3a is essential for the genome integrity and viability of pluripotent cells. Dev Biol 2012, 363:62-73.
43. Vella P., Scelfo A., Jammula S., Chiacchiera F., Williams K., Cuomo A., Roberto A., Christensen J., Bonaldi T., Helin K., Pasini D. Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol Cell 2013, 49:645-656.
44. Zhang Q., Liu X., Gao W., Li P., Hou J., Li J., Wong J. Differential regulation of the ten-eleven translocation (TET) family of dioxygenases by O-linked beta-N-acetylglucosamine transferase (OGT). J Biol Chem 2014, 289:5986-5996.
45. Jang H., Kim T.W., Yoon S., Choi S.Y., Kang T.W., Kim S.Y., Kwon Y.W., Cho E.J., Youn H.D. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 2012, 11:62-74.
46. Myers S.A., Panning B., Burlingame A.L. Polycomb repressive complex 2 is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic stem cells. Proc Natl Acad Sci U S A 2011, 108:9490-9495.
47. Zhang L., Rayner S., Katoku-Kikyo N., Romanova L., Kikyo N. Successful co-immunoprecipitation of Oct4 and Nanog using cross-linking. Biochem Biophys Res Commun 2007, 361:611-614.
48. Lam C.S., Mistri T.K., Foo Y.H., Sudhaharan T., Gan H.T., Rodda D., Lim L.H., Chou C., Robson P., Wohland T., Ahmed S. DNA-dependent Oct4-Sox2 interaction and diffusion properties characteristic of the pluripotent cell state revealed by fluorescence spectroscopy. Biochem J 2012, 448:21-33.
49. Brockdorff N. Noncoding RNA and Polycomb recruitment. RNA 2013, 19:429-442.
50. Tsai M.C., Manor O., Wan Y., Mosammaparast N., Wang J.K., Lan F., Shi Y., Segal E., Chang H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689-693.
51. Yousefi M., Hajihoseini V., Jung W., Hosseinpour B., Rassouli H., Lee B., Baharvand H., Lee K., Salekdeh G.H. Embryonic stem cell interactomics: the beginning of a long road to biological function. Stem Cell Rev 2012, 8:1138-1154.
52. Orkin S.H., Hochedlinger K. Chromatin connections to pluripotency and cellular reprogramming. Cell 2011, 145:835-850.
53. Kim J., Chu J., Shen X., Wang J., Orkin S.H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008, 132:1049-1061.
54. Ang Y.S., Tsai S.Y., Lee D.F., Monk J., Su J., Ratnakumar K., Ding J., Ge Y., Darr H., Chang B., Wang J., et al. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 2011, 145:183-197.
55. Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A., Rappsilber J., Helin K. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-348.
56. Whyte W.A., Bilodeau S., Orlando D.A., Hoke H.A., Frampton G.M., Foster C.T., Cowley S.M., Young R.A. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 2012, 482:221-225.
57. Baltus G.A., Kowalski M.P., Tutter A.V., Kadam S. A positive regulatory role for the mSin3A-HDAC complex in pluripotency through Nanog and Sox2. J Biol Chem 2009, 284:6998-7006.
58. Huangfu D., Maehr R., Guo W., Eijkelenboom A., Snitow M., Chen A.E., Melton D.A. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008, 26:795-797.
59. Nichols J., Smith A. Naive and primed pluripotent states. Cell Stem Cell 2009, 4:487-492.
60. Hockemeyer D., Soldner F., Beard C., Gao Q., Mitalipova M., DeKelver R.C., Katibah G.E., Amora R., Boydston E.A., Zeitler B., Meng X., et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 2009, 27:851-857.
61. Hockemeyer D., Wang H., Kiani S., Lai C.S., Gao Q., Cassady J.P., Cost G.J., Zhang L., Santiago Y., Miller J.C., Zeitler B., et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 2011, 29:731-734.
62. Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
63. Mali P., Yang L., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., Norville J.E., Church G.M. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.
64. Shen X., Kim W., Fujiwara Y., Simon M.D., Liu Y., Mysliwiec M.R., Yuan G.C., Lee Y., Orkin S.H. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 2009, 139:1303-1314.
65. Pasini D., Cloos P.A., Walfridsson J., Olsson L., Bukowski J.P., Johansen J.V., Bak M., Tommerup N., Rappsilber J., Helin K. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 2010, 464:306-310.
66. Mallanna S.K., Ormsbee B.D., Iacovino M., Gilmore J.M., Cox J.L., Kyba M., Washburn M.P., Rizzino A. Proteomic analysis of Sox2-associated proteins during early stages of mouse embryonic stem cell differentiation identifies Sox21 as a novel regulator of stem cell fate. Stem Cells 2010, 28:1715-1727.
67. Gao Z., Cox J.L., Gilmore J.M., Ormsbee B.D., Mallanna S.K., Washburn M.P., Rizzino A. Determination of protein interactome of transcription factor Sox2 in embryonic stem cells engineered for inducible expression of four reprogramming factors. J Biol Chem 2012, 287:11384-11397.
68. Lai Y.S., Chang C.W., Pawlik K.M., Zhou D., Renfrow M.B., Townes T.M. SRY (sex determining region Y)-box2 (Sox2)/poly ADP-ribose polymerase 1 (Parp1) complexes regulate pluripotency. Proc Natl Acad Sci U S A 2012, 109:3772-3777.
69. Yakulov T., Raggioli A., Franz H., Kemler R. Wnt3a-dependent and -independent protein interaction networks of chromatin-bound beta-catenin in mouse embryonic stem cells. Mol Cell Proteomics 2013, 12:1980-1994.